iShares Evolved U.S. Innovative Healthcare ETF
IEIH
IEIH was delisted on the 22nd of August, 2022.
9 hedge funds and large institutions have $1.47M invested in iShares Evolved U.S. Innovative Healthcare ETF in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
50% more funds holding
Funds holding: 6 → 9 (+3)
6% more capital invested
Capital invested by funds: $1.39M → $1.47M (+$81.5K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$442K |
| 2 |
PIMG
Patriot Investment Management Group
Knoxville,
Tennessee
|
+$241K |
| 3 |
FP
Financial Perspectives
Minneapolis,
Minnesota
|
+$166K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$147K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$2.87K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.15M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$14.4K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$29 |
IEIH Hedge Fund Activity: Q2 2020 in Review
9 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in iShares Evolved U.S. Innovative Healthcare ETF (IEIH) for Q2 2020, worth a combined $1.47M — up 5.9% from $1.39M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new IEIH positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $442K. The largest seller was BlackRock, cutting an estimated $1.15M.
- 9 institutional investors held iShares Evolved U.S. Innovative Healthcare ETF (IEIH) as of Q2 2020, up from 6 in Q1 2020.
- Funds reported $1.47M of iShares Evolved U.S. Innovative Healthcare ETF stock for Q2 2020, up 5.9% quarter-over-quarter.
- 4 funds opened new iShares Evolved U.S. Innovative Healthcare ETF positions in Q2 2020 and 1 closed out, a net change of +3 holders.
- The largest iShares Evolved U.S. Innovative Healthcare ETF buyer in Q2 2020 was Susquehanna International Group, an estimated $442K added.
- The largest iShares Evolved U.S. Innovative Healthcare ETF seller in Q2 2020 was BlackRock, an estimated $1.15M sold.
Based on aggregated 13F filings for Q2 2020.